New biotechnology combines targeted and immune therapies to kill treatment-resistant cancer cells
Targeted therapies specifically attach to and hinder cancer-causing proteins, but cancer cells can quickly evolve to thwart their action. A second drug class, immunotherapies, harnesses the immune system to attack cancer cells, but these…